Micromet

Semi-Annual Changes to the NASDAQ Biotechnology Index

euroinvestor.co.uk
15-Nov-2008 3 related
        

NEW YORK, Nov. 14, 2008 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. ("NASDAQ") (Nasdaq:NDAQ) announced today the results of the semi-annual re-ranking of the NASDAQ Biotechnology Index(r) (Nasdaq.. - Read more

add comment
                   

Micromet to Present Interim Data from Two Studies for T Cell Engaging BiTE Antibody Blinatumomab...

finanznachrichten.de
13-Nov-2008 5 related
        

BETHESDA, Md., Nov. 13 /PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that two...

add comment
                   

Micromet, Inc. Reports Third Quarter 2008 Financial Results (PR Newswire)

yahoo.com
06-Nov-2008 3 related
        

Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced its financial results for the third quarter and nine...

add comment

Affitech Acquires Pharmexa's Diabody Technology

redorbit.com
28-Oct-2008
        

OSLO, Norway, October 28 /PRNewswire/ -- Affitech AS, the human therapeutic antibody company, today announced that it had acquired the full rights to the innovative diabody technology originally owned by Pharmexa A/S, a leading...

add comment

Affitech Acquires Pharmexa's Diabody Technology (PR Newswire)

yahoo.com
28-Oct-2008
        

Affitech AS, the human therapeutic antibody company, today announced that it had acquired the full rights to the innovative diabody technology originally owned by Pharmexa A/S, a leading Danish immunotherapeutic and vaccine...

add comment